Next Generation Sequencing (NGS) Miseq Illumina System

The Centers for Disease Control and Prevention (CDC) located in 1600 Clifton Road NE, Atlanta Georgia, intends to award a sole source, Firm Fixed Price contract for Next Generation Sequencing Miseq Illumina System to BIOMEDIC SCIENCE MATERIAL JOINT STOCK COMPANY, 3rd Floor, T2 Times Tower, 35 Le Van Luong, Nhan, Ha Noi, Vietnam, to assist the Ministry of Health with the establishment of a National Public Health Reference Laboratory network. Biomedic Science Material Joint Stock Company (“Channel Partner”), is a selected, authorized and exclusive Channel Partner of Illumina branded products of Illumina, Inc. The NGS system for rapid detection of novel and emerging pathogens, that can ultimately be used to better understand the spread of disease is now considered an essential tool for public health laboratories. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested parties may submit their interest to this notice by 11:00 pm eastern time, April 23, 2021 via email to the contract specialist Idrees Raheem at [email protected] . This notice of intent is not a request for competitive quotations. All interested parties responses received by the closed date specified herein will be reviewed by the Government. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. The Centers for Disease Control and Prevention (CDC) will not be responsible for any costs incurred by interested parties in responding to this notice of intent.